The risk of several types of cancers is increased in immunosuppressive conditions. Of these, non-Hodgkin's lymphoma is most consistently associated with a wide spectrum of immunosuppressive conditions, whether of congenital, iatogenic or HIV-associated origin. In particular, studies of therapeutic immunosuppressive conditions have shown increased risks for squamous cell skin cancer and soft tissue sarcomas, especially Kaposi's sarcoma, but excesses of myeloid leukaemia, malignant melanoma, anogenital cancer and hepatoma have also been reported (Hoover and Fraumeni, 1973; Harwood et al., 1979; Kinlen et al., 1979; Penn, 1986; Birkeland et al., 1995) . Based on present evidence, the distribution of neoplastic diseases reported among HIV-induced immunosuppressed subjects appears to fall into a similar pattern (Rabkin and Blattner, 1991) .
Many of the tumours linked with immunosuppression have been suspected to have a viral cause. One mechanism might be the failure to eliminate cells proliferating under the influence of virus replication. Whereas two potentially Epstein-Barr virus (EBV) -associated neoplasms, Burkitt's lymphoma and Hodgkin's disease, appears to be influenced by HIV-induced immunosuppression (Rabkin and Blattner, 1991; Boiocchi et al., 1993; Boyle et al., 1993) , little has been reported on nasopharyngeal carcinoma, another EBVassociated tumour (Zur Hausen et al., 1970 : Raab-Traub, 1992 . In the present study we took advantage of a programme which links AIDS and cancer registries in nine localities of the USA to study a potential influence of severe and long-term immunosuppression on the development of this tumour.
Materials and methods
AIDS and cancer registries were linked in California, Florida, metropolitan Atlanta and New Jersey as described in detail elsewhere . The analysis was restricted to people aged below 70 years and the periods in which both registries were functioning.
The International Classification of Diseases for Oncology (ICD-0) was used to define the codes for nasopharyngeal carcinoma (topography code 147; histology codes 80103, 80323, 80413-33, 80513-23, 80703-63, 80823, 80943-53, 81203, 81223, 81313) . We calculated the expected incidence of nasopharyngeal cancers after AIDS diagnosis by multiplying SEER (Surveillance, Epidemiology and End Results Programme) age-specific incidence rates by the corresponding person-years at risk after AIDS diagnosis. A person was at risk until the occurrence of either cancer or death, and censored at 2.25 years after the AIDS diagnosis, or when cancer surveillance ended, whichever came first. This restriction was applied to limit problems associated with loss to follow-up (e.g. unregistered deaths or migration away from a registration area after an AIDS diagnosis but before a cancer diagnosis). The observed number of cases was then compared with the expected number to give observed/ expected ratios (relative risk) and Poisson-distributed 95% confidence interval (CI) (Breslow and Day, 1987) To estimate the expected number of cancers that would have occurred among HIV-infected persons who die before their AIDS diagnosis, we used modifications of techniques previously described in detail (Feldman et al., 1986; Melbye et al., 1994) .
Results
The linkage analysis included 859 398 reports of cancer and 50 050 reports of AIDS. As shown in Table I , we found four patients with a diagnosis of NPC within 5 years before their AIDS diagnosis. Two were squamous cell carcinomas and two lymphoepithelial carcinomas. Overall, the relative risk of being diagnosed with NPC within 5 years before and up to 2.25 years after the AIDS diagnosis was 2.4 (95% CI 0.7-6.2) (Table II) . There was no indication of a significantly increased risk up to or after the AIDS diagnosis.
Discussion
The diagnosis of AIDS is generally preceded by several years of increasing immunodeficiency which makes this condition a unique way to study the influence of long-term immunosuppression on cancer development. 2.43 (0.66-6.22) increased risk of between 160 and 700 for non-Hodgkins lymphoma . and an 84-fold increased risk of anal cancer . With respect to invasive cervical cancer the risk has only been found to be modestly increased (4-6-fold) (Cote et al.. 1993 In the present study we found a relative risk of 2.4 for NPC in HIV-infected subjects who developed AIDS which. however, was not significantly different from that in the general population. Recently. a Nordic study was published which analysed cancer risk after renal transplantation based on 5 692 recipients treated during the period 1964-82. In this study the risk for NPC was not increased (Birkeland et al.. 1995, and H.H. Storm, Danish Cancer Registry, personal communication). Thus, despite the molecular evidence for a viral association with this tumour, it appears that failure of immunity does not significantly affect its incidence.
